查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008719

生物感測器市場報告：按產品、技術、應用、最終用途和地區分類（2026-2034 年）

Biosensors Market Report by Product, Technology, Application, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球生物感測器市場規模達331億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到589億美元，2026年至2034年的複合年成長率（CAGR）為6.42%。北美地區憑藉其完善的醫療保健基礎設施、強大的研發投入、對個人化醫療的高需求以及眾多大型生物感測器製造商和技術公司的存在，正引領著市場成長。技術進步、慢性病盛行率上升、即時檢測（POC​​T）需求成長、在醫療保健、食品和環境監測等領域的應用不斷擴展、政府舉措、研發投入、穿戴式生物感測器的出現以及對精準醫療和個人化治療方法的日益關注，都是推動市場成長的因素。

市場規模及預測：

  • 預計到 2025 年，生物感測器市場規模將達到 331 億美元。
  • 預計到 2034 年，該市場規模將達到 589 億美元，2026 年至 2034 年的複合年成長率為 6.42%。

主要部分：

  • 產品：非穿戴式生物感測器因其在臨床診斷、醫學檢測和實驗室應用中的廣泛使用而佔據最大的市場佔有率。它們具有高精度、多功能性，並且易於整合到現有醫療系統中，無需持續佩戴即可實現高效的疾病監測和即時診斷。
  • 技術方面：電化學生物感測器因其高靈敏度、低成本、易用性和快速響應時間而佔據最大的市場佔有率。其可靠的性能、便攜性以及檢測多種分析物的能力使其廣泛應用於各種領域，包括血糖監測和環境檢測。
  • 應用領域：隨著糖尿病在全球範圍內的日益流行，血糖值監測已成為最大的應用領域。隨著對連續血糖監測需求的成長，電化學生物感測器提供了一種經濟高效的解決方案。這些設備能夠提供準確的即時測量結果，幫助患者管理自身病情並預防併發症。
  • 最終用途：即時檢測因其便捷、快速以及能夠在患者照護現場立即提供檢測結果而佔據市場主導地位。這減少了患者前往檢查室的次數，加快了診斷速度，並改善了患者的治療效果。它在緊急情況和偏遠地區尤為有利。
  • 區域：北美憑藉其完善的醫療保健基礎設施、對創新醫療設備日益成長的需求、大量的研發投入以及眾多主要生物感測器製造商的存在，引領著市場發展。此外，優惠的醫保報銷政策和龐大的老齡人口也鞏固了該地區的市場主導地位。

主要企業：

  • 生物感測器市場的主要企業包括雅培實驗室、Agamatrix（WaveForm Technologies Inc.）、杜邦公司、羅氏公司、通用電氣公司、LifeScan（Platinum Equity LLC）、Medtronic、Nova Biomedical公司、PHC Holdings公司、西門子公司和賽默飛世爾科技公司。

市場成長的主要促進因素：

  • 慢性病盛行率上升：慢性病盛行率的上升正在推動生物感測器市場的成長。這是因為持續監測對於症狀管理和早期發現至關重要。生物感測器能夠即時追蹤關鍵健康參數，從而改善慢性病患者的生活品質並預防併發症。
  • 生物製程監測技術的進步：生物製程監測技術的改進，尤其是在生物技術和製藥領域，正在推動市場成長。對生物反應器過程的即時監測提高了細胞培養、發酵和生物技術應用的準確性和效率。先進的生物感測器能夠檢測低濃度分子，從而最佳化生產和生物製程管理。
  • 技術進步：諸如自發光生物感測器和量子非彈性電子隧道等技術進步正在提升生物感測器檢測極低濃度生物分子的能力。這些創新實現了無標定即時診斷，提高了檢測精度，並拓展了生物感測器在醫療保健、環境監測和現場診斷等領域的應用範圍。
  • 穿戴式健康設備的成長：配備先進生物感測器的穿戴式設備的日益普及正在對市場產生積極影響。這些設備能夠持續監測心率和血糖值等生命徵象，提供便利的即時健康數據，尤其對慢性病患者更是如此。
  • 政府財政支持：政府對研發的承諾和財政支持對於推動市場成長至關重要。這些投資旨在使生物感測器具備功能性、準確性和可負擔性，而公私合營正在加速個人化醫療、疾病監測和診斷領域的發展。
  • 健康意識的提升：公眾健康意識的增強推動了生物感測器設備的普及。隨著人們越來越積極主動地管理自身健康，對能夠監測生命徵象、早期發現慢性疾病並支持預防醫學的個人健康追蹤設備的需求也日益成長。

未來展望：

  • 強勁成長前景：生物感測器市場正經歷強勁成長，這主要得益於技術進步、醫療需求成長以及對個人化醫療日益成長的需求。穿戴式和非侵入式感測器的創新，以及人們對慢性病管理意識的提高，共同創造了全球良好的市場前景。
  • 市場發展：生物感測器市場正隨著小型化、與行動醫療平台整合以及精度提升等技術的進步而快速發展。這些進步正在擴大生物感測器的應用範圍，使其涵蓋醫療診斷和環境監測等領域，從而為市場成長和創新創造新的機會。

隨著世界人口老化，人們對可靠有效的醫療保健方案的需求日益成長。生物感測器對於疾病監測、慢性病（如糖尿病）管理以及早期診斷至關重要。隨著個人化醫療和預防醫學的興起，生物感測器在即時監測健康狀況和改善患者預後方面變得不可或缺。此外，人們也需要非侵入性監測方法，例如穿戴式生物感測器。這些設備無需侵入性操作即可進行連續監測，從而提高患者的舒適度和治療依從性。這一趨勢在慢性病（如糖尿病）的管理中尤其有利，使患者無需在皮膚上紮針即可監測血糖值。此外，政府和私人機構都在為生物感測器技術的研究舉措提供大量資金。由於醫療技術的創新，特別是旨在改善公眾健康狀況的醫療保健解決方案的投資，生物感測器領域正在取得顯著進展。這些資金支持正在加速創新生物感測器應用的發展。

生物感測器市場的發展趨勢：

慢性病增多

糖尿病、心臟病和呼吸系統疾病等慢性病發病率的上升推動了生物感測器市場的成長。持續監測對於控制症狀、預防併發症和提高患者的生活品質至關重要。生物感測器提供了一種切實可行的方法，能夠即時監測關鍵健康指標並支持早期發現異常。例如，糖尿病患者使用持續血糖監測儀來控制血糖值並調整胰島素劑量。同樣，心臟病患者依靠生物感測器來追蹤心率並識別心律不整。隨著全球慢性病盛行率的上升，對能夠提供持續健康監測的生物感測器的需求也不斷成長。 2025年，Ottai推出了一款由人工智慧驅動的穿戴式生物感測器，旨在持續監測和管理慢性病。該設備利用即時生物標記追蹤、語音啟動記錄和人工智慧分析，提供個人化的生活方式提案。它還可以與醫療保健應用程式整合，提供擴充性的、以患者為中心的護理解決方案。

生物過程監測的進展

生物過程監測技術的進步正在推動市場成長，尤其是在生物技術和製藥行業。即時監測生物反應器過程對於維持細胞培養、發酵和各種生物技術應用的品質、準確性和效率至關重要。具備先進功能的生物感測器，例如能夠檢測極低濃度的關鍵分子，正在提高生物製程的精確度。這些感測器有助於最佳化培養基製備和生物製程控制，在製藥、生物技術和替代蛋白等領域的規模化生產中發揮關鍵作用。順應這一趨勢，The Cultivated B 於 2025 年推出了一款由人工智慧驅動的多通道生物感測器，用於即時監測生物反應器過程，從而提高細胞培養和發酵的準確性和效率。這些線上感測器能夠檢測關鍵分子的超低濃度，並利用人工智慧最佳化培養基成分和生物過程控制。這項創新技術支持生物技術、製藥和替代蛋白質領域的規模化應用。

生物感測器靈敏度和小型化方面的創新

技術進步，例如自發光生物感測器的開發和量子非彈性電子穿隧效應的應用，正在提升生物感測器檢測極低濃度生物分子（低至皮克級）的能力。這些進步使得無標定即可進行即時診斷，並能快速獲得高準確度和結果。開發高靈敏度、小型化和攜帶式設備的能力拓展了生物感測器的應用範圍，使其能夠應用於包括醫療和環境監測在內的各個領域。隨著生物感測器的效率和多功能性不斷提高，其在照護現場診斷和現場監測中的應用日益廣泛，加速了生物感測器技術在醫療和工業領域的融合。 2025年，瑞士洛桑聯邦理工學院（EPFL）的科學家開發了世界上首個利用量子非彈性電子穿隧效應的自發光生物感測器。此感測器無需外部光源即可在單一晶片上實現發光和檢測。這種小型化、超靈敏的設備能夠偵測皮克級的生物分子，使其成為即時、無標定診斷的理想選擇。這項創新技術可望實現擴充性、攜帶式生物感測器，應用於醫療和環境領域。

生物感測器市場成長要素：

穿戴式裝置的廣泛應用

智慧型手錶、健身追蹤器和健康監測手環等穿戴式裝置的日益普及，為市場帶來了良好的前景。這些設備配備了先進的生物感測器，使用戶能夠持續監測心率、血糖值和血氧飽和度等生命徵象，從而更有效地管理自身健康。穿戴式裝置對於慢性病患者或注重健康改善的人尤其有用，它們無需定期就醫即可提供便利的即時健康資訊。除了對個人化健康管理的需求外，穿戴式科技的進步，例如電池續航力和感測器精度的提升，也不斷拓展其應用範圍。 2024年，Biolinq成功資金籌措5,800萬美元，用於改進其穿戴式皮內葡萄糖生物感測器。該感測器透過植入皮下的微型感測器追蹤血糖值和活動水平。這項突破性設備旨在簡化代謝健康監測，凸顯了穿戴式裝置在個人化醫療領域日益成長的重要性。

政府措施和財政援助

政府計畫和研發資金支持是推動生物感測器市場擴張的關鍵因素。鑑於生物感測器技術在醫療保健和環境監測領域的重要性，許多政府機構正投入大量資源促進該領域的創新。這些投資旨在提升生物感測器的功能性、準確性和成本效益，從而促進其在各種應用中的使用。此外，公私合作對於個人化醫療、疾病監測和即時診斷等領域生物感測器的發展至關重要。一個值得關注的例子是賓州州立大學於2024年10月宣布的一項150萬美元的美國國家科學基金會（NSF）津貼，該撥款旨在開發人工智慧設計的生物感測器，用於識別神經傳導物質等分子。這項由伊達·埃布拉希米教授主導的計畫涵蓋了K-12 STEM教育推廣、本科生研究和產業合作，凸顯了學術界、產業界和政府為加速生物感測器發展而開展的合作努力。

人們越來越關注健康和保健

公眾健康意識的不斷提高是推動生物感測器設備普及的關鍵因素。隨著人們越來越積極主動地管理自身健康，對能夠追蹤健康狀況的設備的需求也日益成長。越來越多的人希望監測心率、血糖值和血壓等關鍵指標，以改善健康狀況並預防疾病。這種自我監測的趨勢尤其受到早期發現糖尿病和高血壓等慢性疾病需求的推動。健身追蹤器和智慧型手錶等設備能夠提供即時健康信息，並提供有關整體健康狀況的重要見解。順應這一趨勢，雅培公司於2024年在美國推出了Lingo，這是一款商用連續血糖監測（CGM）生物感測器，此前該產品已於6月獲得美國食品藥物管理局（FDA）的核准。 Lingo基於FreeStyle Libre技術開發，可為非胰島素使用者提供即時血糖值追蹤、健康洞察和習慣改善指導。在預防醫學意識不斷增強的背景下，生物感測器市場持續成長，使人們能夠有效管理自身健康。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球生物感測器市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 穿戴式生物感測器
  • 非穿戴式生物感測器

第7章 市場區隔：依技術分類

  • 電化學生物感測器
  • 光學生物感測器
  • 壓電感測器
  • 熱生物感測器
  • 奈米機械生物感測器
  • 其他

第8章 市場區隔：依應用領域分類

  • 血糖測試
  • 膽固醇檢測
  • 血氣分析
  • 妊娠測試
  • 藥物發現
  • 傳染病檢查
  • 其他

第9章 市場區隔：依最終用途分類

  • 即時檢測
  • 居家醫療診斷
  • 研究所
  • 安全與生物防禦
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • AgaMatrix Inc.（WaveForm Technologies Inc）
    • DuPont de Nemours Inc.
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • LifeScan Inc.（Platinum Equity LLC）
    • Medtronic PLC
    • Nova Biomedical Corporation
    • PHC Holdings Corporation
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4130

The global biosensors market size reached USD 33.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 58.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.42% during 2026-2034. North America leads the market attributed to robust healthcare infrastructure, strong investment in research operations, high demand for personalized medicine, and the presence of leading biosensor manufacturers and tech companies. Technological advancements, rising prevalence of chronic diseases, increasing demand for point-of-care testing (POCT), the expanding applications in healthcare, food, and environmental monitoring, government initiatives, investments in research and development (R&D), emergence of wearable biosensors, and the growing focus on precision medicine and personalized treatment approaches are some of the factors favoring the market growth.

MARKET SIZE & FORECASTS:

  • Biosensors market was valued at USD 33.1 Billion in 2025.
  • The market is projected to reach USD 58.9 Billion by 2034, at a CAGR of 6.42% from 2026-2034.

DOMINANT SEGMENTS:

  • Product: Non-wearable biosensors hold the biggest market share due to their widespread use in clinical diagnostics, medical testing, and laboratory applications. They offer high accuracy, versatility, and ease of integration into existing healthcare systems, enabling efficient disease monitoring and real-time diagnostics without requiring constant wear.
  • Technology : Electrochemical biosensors account for the largest market share owing to their high sensitivity, low cost, ease of use, and fast response times. They are widely used in various applications like glucose monitoring and environmental testing because of their reliable performance, portability, and ability to detect a wide range of analytes.
  • Application : Blood glucose testing represents the largest segment because of the growing prevalence of diabetes worldwide. With the need for continuous glucose monitoring, electrochemical biosensors offer a cost-effective and efficient solution. This device provides real-time, accurate measurements, helping individuals manage their condition and avoid complications.
  • End Use : Point of care testing dominates the market attributed to its convenience, speed, and ability to provide immediate results at the site of patient care. It reduces the need for laboratory visits, enables faster diagnosis, improves patient outcomes, and is especially beneficial in emergency situations and remote areas.
  • Region: North America dominates the market accredited to robust healthcare infrastructure, growing demand for innovative medical devices, significant investments in research operations, and the presence of leading biosensor manufacturers. Additionally, favorable reimbursement policies and a large aging population further support the market dominance of the region.

KEY PLAYERS:

  • The leading companies in biosensors market include Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG, and Thermo Fisher Scientific Inc.

KEY DRIVERS OF MARKET GROWTH:

  • Growing Prevalence of Chronic Illnesses: The rising prevalence of chronic illnesses is driving the biosensors market as continuous monitoring becomes essential for symptom management and early detection. Biosensors enable real-time tracking of critical health parameters, improving the quality of life and preventing complications in patients with chronic conditions.
  • Bioprocess Monitoring Advancements: Improvements in bioprocess monitoring, particularly in biotechnology and pharmaceuticals, is propelling the market growth. Real-time monitoring of bioreactor processes improves the accuracy and effectiveness of cell culture, fermentation, and biotechnological applications. Advanced biosensors enable the detection of low molecule concentrations, optimizing production and bioprocess management.
  • Improvements in Technology: Technological advancements, such as self-illuminating biosensors and quantum inelastic electron tunneling, are enhancing biosensors' ability to detect biomolecules at extremely low concentrations. These innovations enable label-free, real-time diagnostics, improving accuracy and expanding biosensors' applications in healthcare, environmental monitoring, and on-site diagnostics.
  • Growth of Wearable Health Devices: The growing adoption of wearable devices equipped with advanced biosensors is positively influencing the market. These devices enable continuous observation of vital signs like heart rate and glucose levels, offering convenience and real-time health data, especially for individuals with chronic conditions.
  • Financial Government Support: Government initiatives and financial support for research and development (R&D) are crucial for driving the growth of the market. These investments aim to improve biosensor functionality, accuracy, and affordability, while public-private collaborations accelerate advancements in personalized medicine, disease monitoring, and diagnostics.
  • Awareness about Health and Wellness: Growing public awareness about health and wellness is driving the adoption of biosensor-enabled devices. As individuals become more proactive about their health, there is a rise in the demand for personal health tracking devices to monitor vital signs and identify chronic conditions early, supporting preventive care.

FUTURE OUTLOOK:

  • Strong Growth Outlook : The biosensors market is experiencing a strong growth owing to improvements in technology, growing healthcare needs, and rising demand for personalized medicine. Innovations in wearable and non-invasive sensors, along with growing awareness about chronic disease management, are offering a favorable market outlook globally.
  • Market Evolution : The biosensors market is evolving with rapid technological advancements, such as miniaturization, integration with mobile health platforms, and improved accuracy. These developments are broadening the range of applications, such as medical diagnostics and environmental monitoring, creating new opportunities for market growth and innovation.

With the aging global population, there is a rise in the demand for dependable and effective healthcare options. Biosensors are essential for disease monitoring, chronic condition management, such as diabetes, and facilitating early diagnosis. As personalized and preventive healthcare gains attention, biosensors are becoming essential for monitoring health in real-time, enhancing patient results. In addition, non-invasive monitoring methods, like those employed in wearable biosensors, are sought after. These devices provide the benefit of ongoing monitoring without requiring invasive methods, enhancing patient comfort and adherence. This trend is especially advantageous for handling chronic illnesses, such as diabetes, enabling patients to track glucose levels without needing to puncture their skin. Apart from this, both governments and private organizations are significantly funding research initiatives in biosensor technologies. Investment in medical technology innovation, particularly in healthcare solutions aimed at enhancing public health outcomes, are resulting in substantial progress in biosensors. This financial assistance fosters the creation of innovative biosensor applications.

BIOSENSORS MARKET TRENDS:

Increasing Prevalence of Chronic Diseases

The rising occurrence of chronic illnesses, like diabetes, heart diseases, and breathing disorders, is contributing to the growth of the biosensors market. Continuous monitoring is essential for managing symptoms, preventing complications, and enhancing patients' quality of life under these conditions. Biosensors offer a practical approach by facilitating instant monitoring of essential health indicators, which aids in the prompt identification of abnormalities. For instance, individuals with diabetes utilize continuous glucose monitors to oversee blood sugar levels and modify insulin amounts. Likewise, people with cardiac issues depend on biosensors to track heart rate and identify irregular rhythms. With the growing prevalence of chronic illnesses worldwide, the need for biosensors that provide continuous health monitoring is escalating. In 2025, Ottai launched its AI-powered wearable biosensor designed for continuous monitoring and management of chronic diseases. The device uses real-time biomarker tracking, voice-activated logging, and AI-driven insights to deliver personalized lifestyle recommendations. It integrates with health apps to offer a scalable, patient-centric care solution.

Advancements in Bioprocess Monitoring

Improvements in bioprocess monitoring are impelling the growth of the market, especially in the biotechnology and pharmaceutical industries. Real-time observation of bioreactor processes is crucial for maintaining the quality, precision, and effectiveness of cell culture, fermentation, and various biotechnological applications. Biosensors with sophisticated features, including identifying extremely low levels of important molecules, are improving the accuracy of bioprocesses. These sensors facilitate the optimization of media formulation and bioprocess management, vital for increasing production in sectors, such as pharmaceuticals, biotechnology, and alternative proteins. In line with this trend, in 2025, The Cultivated B launched AI-driven multi-channel biosensors for real-time monitoring of bioreactor processes, enhancing accuracy and efficiency in cell culture and fermentation. These inline sensors detect ultra-low concentrations of key molecules and use AI to optimize media formulation and bioprocess control. The innovation supports scalable applications across biotech, pharma, and alternative proteins.

Innovation in Biosensor Sensitivity and Miniaturization

Technological progress, including the creation of self-illuminating biosensors and the application of quantum inelastic electron tunneling, is improving the capacity of biosensors to identify biomolecules at remarkably low concentrations, even down to the picogram level. These advancements allow for instantaneous, label-free diagnostics, providing excellent accuracy and quicker outcomes. The capacity to develop highly sensitive, small, and portable devices enhances the possible uses of biosensors, making them applicable across various sectors, such as healthcare and environmental monitoring. With the growing efficiency and versatility of biosensors, their application in point-of-care diagnostics and on-site monitoring is rising, enhancing the integration of biosensor technology in medical and industrial fields. In 2025, scientists at EPFL developed the first self-illuminating biosensor using quantum inelastic electron tunneling, enabling light generation and detection on a single chip without external light sources. This compact, ultra-sensitive device detects biomolecules at picogram levels, ideal for real-time, label-free diagnostics. The innovation promises scalable, handheld biosensors for medical and environmental applications.

BIOSENSORS MARKET GROWTH DRIVER:

Increasing Adoption of Wearable Devices

The growing use of wearable gadgets like smartwatches, fitness trackers, and health-monitoring bands is offering a favorable market outlook. These gadgets, equipped with sophisticated biosensors, allow users to consistently monitor vital signs like heart rate, glucose levels, and oxygen saturation, enhancing their ability to manage health more efficiently. Wearable devices are especially useful for people with chronic illnesses or those prioritizing wellness, providing convenience and immediate health information without the need for regular doctor appointments. The need for tailored health tracking, along with enhancements in wearable tech, such as better battery longevity and sensor precision, is broadening their application. In 2024, Biolinq secured $58 million to enhance its wearable intradermal glucose biosensor, which tracks glucose levels and activity through microsensors placed under the skin. This groundbreaking gadget aimed to streamline metabolic health monitoring, emphasizing the increasing importance of wearables in individualized healthcare.

Government Initiatives and Funding

Government programs and financial support for research and development (R&D) are essential elements propelling the expansion of the biosensors market. Acknowledging the significance of biosensor technologies for healthcare and environmental monitoring, numerous governing bodies are dedicating substantial resources to foster innovation in this area. These investments aim to enhance biosensor functionality, increase precision, and reduce costs, thereby facilitating broader accessibility for various applications. Furthermore, collaborations between the public and private sectors are crucial for advancing biosensors in personalized medicine, disease monitoring, and point-of-care diagnostics. A notable example is Penn State's announcement in October 2024 of a $1.5 million NSF grant aimed at developing AI-designed biosensors for identifying molecules, such as neurotransmitters. Directed by Professor Aida Ebrahimi, the initiative encompassed K-12 STEM outreach, undergraduate research, and partnerships with industry, highlighting the collective endeavor of academia, industry, and government to promote biosensor advancements.

Rising Awareness about Health and Wellness

The growing public awareness about health and wellness is a key factor driving the adoption of biosensor-enabled devices. As individuals take more initiative regarding their health, there is an increase in the need for personal health tracking devices. More people are becoming interested in monitoring essential indicators, like heart rate, glucose levels, and blood pressure, to improve their health and prevent medical problems. This transition towards self-monitoring is especially driven by the need for early identification of chronic illnesses such as diabetes and hypertension. Gadgets such as fitness trackers and smartwatches provide instant health information, offering crucial insights into overall well-being. In line with this trend, in 2024, Abbott launched Lingo, its over-the-counter continuous glucose monitoring (CGM) biosensor in the US, following FDA clearance in June. Built on FreeStyle Libre tech, Lingo offered real-time glucose tracking, health insights, and habit coaching for non-insulin users. With increased awareness of preventive care, the biosensor market continues to grow, enabling individuals to manage their health effectively.

BIOSENSORS INDUSTRY SEGMENTATION:

Breakup by Product:

  • Wearable Biosensors
  • Non-Wearable Biosensors

The wearable biosensors segment is driven by the increasing demand for continuous health monitoring and personalized medicine. Consumers are increasingly adopting wearable devices such as smartwatches and fitness trackers that incorporate biosensors to monitor vital signs, physical activity, and other health metrics in real-time. Advances in sensor technology, miniaturization, and wireless connectivity have enhanced the functionality and accuracy of wearable biosensors, making them more attractive to users. Additionally, the growing prevalence of chronic diseases and the aging population are fueling the need for remote patient monitoring and early detection of health issues, further boosting the adoption of wearable biosensors. The integration of biosensors with smartphones and other portable devices facilitates seamless data transmission and analysis, providing users and healthcare providers with valuable insights for managing health and wellness.

The non-wearable biosensors segment is driven by the increasing applications in medical diagnostics, environmental monitoring, and food safety. In medical diagnostics, non-wearable biosensors are widely used for detecting various biomarkers, pathogens, and diseases, offering rapid, accurate, and cost-effective solutions for clinical and laboratory settings. Environmental monitoring applications leverage non-wearable biosensors to detect pollutants, toxins, and other harmful substances in air, water, and soil, contributing to public health and safety. In the food industry, non-wearable biosensors are utilized for quality control and safety assurance by detecting contaminants and ensuring compliance with regulatory standards. The rising awareness about the importance of early disease detection, environmental protection, and food safety is driving the demand for non-wearable biosensors.

Breakup by Technology:

  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Others

The electrochemical biosensors segment is driven by the increasing demand for highly sensitive and selective detection methods in medical diagnostics, environmental monitoring, and food safety. The ability of electrochemical biosensors to provide rapid, accurate, and cost-effective analysis makes them highly desirable across various applications. Advances in nanotechnology and materials science have further enhanced their performance, enabling the development of miniaturized and portable devices. Additionally, the rising prevalence of chronic diseases, such as diabetes, necessitates the widespread use of electrochemical biosensors for continuous glucose monitoring, thereby fueling market growth.

The optical biosensors segment is driven by the increasing need for high-throughput and label-free detection methods in research, clinical diagnostics, and environmental monitoring. Optical biosensors offer exceptional sensitivity and specificity, making them ideal for detecting a wide range of analytes, including biomolecules, pathogens, and pollutants. Advances in photonics and biophotonics have significantly improved the performance of optical biosensors, enabling real-time and multiplexed detection. The growing adoption of point-of-care testing and personalized medicine further boosts the demand for optical biosensors, as they provide rapid and accurate results.

The piezoelectric biosensors segment is driven by the increasing utilization in applications requiring the detection of mechanical changes due to their high sensitivity and rapid response time. These biosensors are particularly effective in detecting mass changes, making them valuable in various fields, including medical diagnostics, environmental monitoring, and industrial processes. The growing demand for portable and non-invasive diagnostic tools is fueling the adoption of piezoelectric biosensors. Furthermore, advancements in piezoelectric materials and microfabrication technologies have enhanced the performance and miniaturization of these sensors, broadening their application scope.

The thermal biosensors segment is driven by the increasing need for highly accurate and reliable temperature-based detection methods in biomedical and industrial applications. Thermal biosensors, which measure changes in temperature as a result of biochemical reactions, offer high sensitivity and specificity. They are widely used in monitoring metabolic activities, detecting pathogens, and assessing food quality. The advancements in microelectromechanical systems (MEMS) and nanotechnology have significantly improved the performance of thermal biosensors, enabling their miniaturization and integration into portable devices.

The nanomechanical biosensors segment is driven by the increasing demand for ultra-sensitive detection methods capable of measuring minute changes at the nanoscale. These biosensors leverage mechanical properties such as mass, stiffness, and surface stress to detect the presence of analytes with high precision. The growing applications in genomics, proteomics, and environmental monitoring are boosting the adoption of nanomechanical biosensors. Advances in nanotechnology and materials science have enabled the development of highly sensitive and miniaturized nanomechanical biosensors, expanding their utility in various fields.

The others segment, which includes emerging biosensor technologies such as magnetic, acoustic, and thermal biosensors, is driven by the increasing need for innovative and versatile detection methods across various industries. These biosensors offer unique advantages, including high sensitivity, specificity, and the ability to detect a wide range of analytes. The growing demand for advanced diagnostic tools, environmental monitoring systems, and food safety solutions is fueling the development and adoption of these biosensors.

Breakup by Application:

  • Blood Glucose Testing
  • Cholesterol Testing
  • Blood Gas Analysis
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease Testing
  • Others

The glucose testing segment is driven by the increasing prevalence of diabetes worldwide, which necessitates continuous monitoring and management of blood glucose levels. Advances in biosensor technology have led to the development of more accurate, user-friendly, and cost-effective glucose monitoring devices, including continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) systems . These innovations have significantly improved patient compliance and outcomes by enabling real-time glucose tracking and data integration with digital health platforms.

The cholesterol testing segment is driven by the increasing incidence of cardiovascular diseases (CVDs), which are closely linked to high cholesterol levels. Early detection and management of cholesterol are crucial for preventing CVDs, leading to a higher demand for cholesterol testing biosensors. Technological advancements have resulted in more reliable and faster cholesterol testing devices, including portable and point-of-care systems that provide immediate results. Additionally, rising health consciousness, routine health check-ups, and the emphasis on preventive healthcare practices have spurred the adoption of cholesterol testing biosensors.

The blood gas analysis segment is driven by the increasing prevalence of respiratory and metabolic disorders that require precise monitoring of blood gas levels. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and renal diseases necessitate regular blood gas analysis to manage and adjust treatment plans effectively. Technological advancements have led to the development of portable and point-of-care blood gas analyzers, making it easier for healthcare providers to perform timely and accurate assessments. Furthermore, the growing adoption of these devices in emergency and critical care settings, where rapid decision-making is crucial, significantly contributes to the market's expansion.

The pregnancy testing segment is driven by the increasing demand for home-based and point-of-care diagnostic solutions that offer convenience and privacy. Technological advancements have led to the development of highly sensitive and easy-to-use pregnancy test kits that provide quick and accurate results. The rising awareness about reproductive health and the importance of early pregnancy detection for better prenatal care have also fueled the demand for these testing kits. Additionally, the increasing prevalence of planned pregnancies, coupled with the availability of affordable and accessible testing solutions, further boosts the market.

The drug discovery segment is driven by the increasing need for efficient and cost-effective methods to identify new therapeutic compounds and evaluate their efficacy and safety. Biosensors offer significant advantages in drug discovery by enabling real-time, high-throughput screening of potential drug candidates. Technological advancements have enhanced the sensitivity and specificity of biosensors, making them invaluable tools in the early stages of drug development. Additionally, the growing prevalence of chronic diseases and the demand for personalized medicine have spurred investment in biosensor technologies to accelerate drug discovery processes.

The infectious disease testing segment is driven by the increasing incidence of infectious diseases globally, necessitating rapid and accurate diagnostic solutions. Biosensors offer significant advantages in the early detection and monitoring of infectious agents, enabling timely intervention and containment. Technological advancements have led to the development of highly sensitive and portable biosensors that can detect a wide range of pathogens, including viruses, bacteria, and fungi. The ongoing threat of pandemics and emerging infectious diseases has further highlighted the importance of efficient diagnostic tools, driving investment and innovation in this segment.

The others segment, encompassing various applications such as environmental monitoring, food safety, and bioprocessing, is driven by the increasing need for real-time, accurate, and cost-effective analytical solutions. In environmental monitoring, biosensors are used to detect pollutants and contaminants, ensuring compliance with regulatory standards and safeguarding public health. In food safety, biosensors provide rapid detection of pathogens and toxins, ensuring the quality and safety of food products.

Breakup by End Use:

  • Point of Care Testing
  • Home Healthcare Diagnostics
  • Research Laboratories
  • Security and Biodefense
  • Others

The point-of-care testing (POCT) segment is driven by the increasing demand for rapid diagnostic results and the need for immediate clinical decision-making. This demand is fueled by the growing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which require continuous monitoring and timely management. Technological advancements in biosensors have made these devices more portable, user-friendly, and capable of delivering accurate results quickly, enhancing their adoption in decentralized settings like clinics, emergency rooms, and even patients' homes. Additionally, the emphasis on reducing healthcare costs and improving patient outcomes has led to a shift towards point-of-care testing, allowing for faster diagnosis and treatment, thus minimizing hospital visits and stays.

The home healthcare diagnostics segment is driven by the increasing preference for convenient and accessible healthcare solutions. With the rise in the aging population and the growing burden of chronic diseases, there is a significant demand for home-based diagnostic tools that enable continuous monitoring and management of health conditions without frequent hospital visits. Advances in biosensor technology have facilitated the development of portable, easy-to-use devices that patients can operate independently, ensuring real-time health monitoring and early detection of potential health issues.

The research laboratories segment is driven by the increasing need for advanced diagnostic and analytical tools in scientific research and development. Biosensors play a crucial role in various research applications, including disease pathology, drug development, environmental monitoring, and biotechnology. The precision, sensitivity, and versatility of biosensors make them indispensable in detecting and quantifying biological molecules and pathogens, facilitating groundbreaking research and innovation. The continuous advancement in biosensor technology, including the integration of nanotechnology and microfluidics, enhances their performance, making them even more valuable in research settings.

The security and biodefense segment is driven by the increasing concerns over bioterrorism, infectious disease outbreaks, and the need for robust public safety measures. Biosensors are critical in this context due to their ability to provide rapid, accurate detection of biological and chemical threats, enabling timely response and mitigation. Governments and defense organizations invest heavily in biosensor technology to enhance national security and safeguard public health. The development of portable and real-time biosensors supports field deployment, making them essential tools for military and homeland security operations.

The others segment is driven by the increasing demand for biosensors in diverse applications beyond traditional healthcare and security uses. This includes industries such as agriculture, food and beverage, environmental monitoring, and industrial processes. In agriculture, biosensors are used for soil and crop health monitoring, ensuring optimal yield and quality. In the food and beverage industry, they are crucial for quality control and safety assurance by detecting contaminants and pathogens. Environmental monitoring applications benefit from biosensors' ability to detect pollutants and toxins in air, water, and soil, contributing to sustainability efforts.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North America regional market is driven by the increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which necessitate advanced diagnostic tools. Additionally, the region benefits from robust healthcare infrastructure, significant investments in research and development, and the presence of major biosensor manufacturers. Government initiatives to promote personalized medicine and growing adoption of wearable biosensors for health monitoring further propel market growth. The high awareness and acceptance of new technologies among consumers and healthcare providers also contribute to the expanding biosensors market in North America.

The Europe regional market is driven by the increasing focus on early disease detection and preventive healthcare, supported by substantial government funding and initiatives. The region's strong regulatory framework ensures high standards for biosensor development and application. Additionally, Europe's aging population contributes to a rising demand for advanced diagnostic solutions, while the presence of leading biosensor companies and extensive research activities foster innovation. Growing applications in environmental monitoring and food safety, along with collaboration between academic institutions and industry players, further accelerate market growth in Europe.

The Asia Pacific regional market is driven by the increasing healthcare needs due to a large and rapidly aging population, along with the rising prevalence of chronic diseases. Economic growth and improving healthcare infrastructure in countries like China and India enhance access to advanced diagnostic tools. Governm

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosensors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Wearable Biosensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Wearable Biosensors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Electrochemical Biosensors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Optical Biosensors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Piezoelectric Biosensors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Thermal Biosensors
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nanomechanical Biosensors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood Glucose Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cholesterol Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Gas Analysis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pregnancy Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Drug Discovery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Infectious Disease Testing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Point of Care Testing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Healthcare Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Security and Biodefense
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AgaMatrix Inc. (WaveForm Technologies Inc)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 DuPont de Nemours Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 General Electric Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 LifeScan Inc. (Platinum Equity LLC)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Medtronic PLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nova Biomedical Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 PHC Holdings Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Siemens AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biosensors Market: Major Drivers and Challenges
  • Figure 2: Global: Biosensors Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Biosensors Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Biosensors Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Biosensors Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Biosensors Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Biosensors Market: Breakup by End Use (in %), 2025
  • Figure 8: Global: Biosensors Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Biosensors (Wearable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Biosensors (Wearable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Biosensors (Non-Wearable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Biosensors (Non-Wearable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Biosensors (Electrochemical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Biosensors (Electrochemical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Biosensors (Optical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Biosensors (Optical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Biosensors (Piezoelectric) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Biosensors (Piezoelectric) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Biosensors (Thermal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Biosensors (Thermal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Biosensors (Nanomechanical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Biosensors (Nanomechanical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Biosensors (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Biosensors (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Biosensors (Blood Glucose Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Biosensors (Blood Glucose Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Biosensors (Cholesterol Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Biosensors (Cholesterol Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Biosensors (Blood Gas Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Biosensors (Blood Gas Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Biosensors (Pregnancy Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Biosensors (Pregnancy Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Biosensors (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Biosensors (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Biosensors (Infectious Disease Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Biosensors (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Biosensors (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Biosensors (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Biosensors (Point of Care Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Biosensors (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Biosensors (Home Healthcare Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Biosensors (Home Healthcare Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Biosensors (Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Biosensors (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Biosensors (Security and Biodefense) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Biosensors (Security and Biodefense) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Biosensors (Other End uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Biosensors (Other End uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: North America: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: North America: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United States: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United States: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Canada: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Canada: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Asia-Pacific: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Asia-Pacific: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: China: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: China: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Japan: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Japan: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: India: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: India: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: South Korea: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: South Korea: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Australia: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Australia: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Indonesia: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Indonesia: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Europe: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Europe: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Germany: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Germany: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: France: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: France: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: United Kingdom: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: United Kingdom: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Italy: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Italy: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Spain: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Spain: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Russia: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Russia: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Others: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Latin America: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Latin America: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Brazil: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Brazil: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Mexico: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Mexico: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Others: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Middle East and Africa: Biosensors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Middle East and Africa: Biosensors Market: Breakup by Country (in %), 2025
  • Figure 97: Middle East and Africa: Biosensors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Global: Biosensors Industry: SWOT Analysis
  • Figure 99: Global: Biosensors Industry: Value Chain Analysis
  • Figure 100: Global: Biosensors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosensors Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Biosensors Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Biosensors Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Biosensors Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Biosensors Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 6: Global: Biosensors Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Biosensors Market: Competitive Structure
  • Table 8: Global: Biosensors Market: Key Players